Hepatocellular carcinoma combined with sarcomatoid hepatocellular carcinoma: A case report

Jingyi Li,Xizhuang Gao,Kun Zhao,Xiangzheng Meng,Shuwei Liu,Jian Zhang
DOI: https://doi.org/10.1097/md.0000000000037013
IF: 1.6
2024-02-03
Medicine
Abstract:Sarcomatoid hepatocellular carcinoma (SHC) represents an infrequent subtype of hepatocellular carcinoma (HCC) exhibiting characteristics akin to HCC yet displaying concurrent sarcomatoid histology and clinical manifestations. Pathological features of hepatic sarcomatoid carcinoma encompass HCC cells exhibiting heterogeneous sarcomatoid proliferation. The tumor shows highly malignant attributes, including nuclear division, cellular anisotropy, and interstitial fibrosis. Hepatosarcomatoid carcinoma typically exhibits a more aggressive and malignant behavior than conventional HCC. Clinical presentations of hepatic sarcomatoid carcinoma resemble those of HCC, encompassing symptoms like liver mass, abdominal pain, fatigue, reduced appetite, and weight loss. Diagnosis is typically established through imaging modalities (e.g., ultrasound, computed tomography scan, magnetic resonance imaging [MRI], etc) and histopathological analysis (e.g., biopsy). Given the markedly malignant attributes of hepatosarcomatoid carcinoma, treatment poses challenges. Conventional therapeutic approaches encompass surgical resection, liver transplantation, local ablative therapy, chemotherapy, and targeted therapy.
medicine, general & internal
What problem does this paper attempt to address?